Michael Terrence Gibbs - 20 Feb 2024 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role: General Counsel
Signature: /s/ John Sprague, Attorney-in-fact
Issuer symbol: TTOO
Transactions as of: 20 Feb 2024
Net transactions value: $0
Form type: 4
Filing time: 20 Feb 2024, 16:00:33 UTC
Previous filing: 06 Apr 2023
Next filing: 27 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TTOO	Common Stock	Options Exercise		+40	+61%		106	20 Feb 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TTOO	Restricted Stock Units	Options Exercise	$0	-40	-50%	$0.000000	40	20 Feb 2024	Common Stock	40		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2	On February 20, 2022 the reporting person was granted 120 RSU's that vest annually in three substantially equal installments commencing on February 20, 2023.